ClinVar Miner

Submissions for variant NM_001009944.3(PKD1):c.12460C>T (p.Arg4154Cys) (rs115538130)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Mendelics RCV000989445 SCV001139771 uncertain significance Polycystic kidney disease, adult type 2019-05-28 criteria provided, single submitter clinical testing
Cavalleri Lab, Royal College of Surgeons in Ireland RCV001171322 SCV001328269 uncertain significance Chronic kidney disease 2020-05-28 criteria provided, single submitter research PP3, PP5
GeneDx RCV001664593 SCV001875326 likely benign not provided 2021-01-19 criteria provided, single submitter clinical testing This variant is associated with the following publications: (PMID: 32723786, 31157564, 20981092, 10987650, 26139440)
Department of Pathology and Laboratory Medicine,Sinai Health System RCV001292093 SCV001480883 likely benign Polycystic kidney disease no assertion criteria provided clinical testing The PKD1 p.Arg4154Cys variant was identified in 5 of 1254 proband chromosomes (frequency: 0.004) from French, Tunisian and Italian individuals or families with ADPKD and not identified in 300 control chromosomes from healthy individuals (Audrezet_2015_26139440, Carrera_2016_27499327, Perrichot_1999_10987650). In segregation studies, the variant co-occurred with pathogenic PKD1 variants (c.7108T.A (PKD1) p.Cys2370Ser (PKD1)/c.5873G.A (PKD1) p.Trp1958X (PKD1)/c.6727_6730del (PKD1) p.Gln2243AlafsX6) inherited from the probands’ affected parents, while unaffected parents were shown to carry this variant; increasing the likelihood the variant has no clinical significance (Audrezet_2015_26139440). In another proband, the variant co-occurred with a likely pathogenic PKD1 variant (c.9361G> A p.Glu3121Lys) (Carrera_2016_27499327). The p.Arg4154Cys variant was also found in 1 proband’s affected daughter, leading to the variant assessment of likely pathogenic; however, PKD1 was only partially screened, with exons 34 to 46 only being screened . (Perrichot_1999_10987650). The variant was also identified in dbSNP (ID: rs115538130) as “NA”, LOVD 3.0, ADPKD Mutation Database (classified likely pathogenic, based on Perrichot et al. (1999)), and was not identified in ClinVar, Clinvitae, COGR, and PKD1-LOVD. The variant was identified in control databases in 269 (6 homozygous) of 265106 chromosomes at a frequency of 0.001 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). Observations by population include African in 127 (2 homozygous) of 23396 chromosomes (freq: 0.005), “Other” in 2 of 6220 chromosomes (freq: 0.0003), Latino in 29 (1 homozygous) of 33684 chromosomes (freq: 0.000861), European Non-Finnish in 32 of 119926 chromosomes (freq: 0.0003), East Asian in 8 of 18612 chromosomes (freq: 0.0004), and South Asian in 71 (3 homozygous) of 29734 chromosomes (freq: 0.002); it was \not observed in the Ashkenazi Jewish and European Finnish populations. The p.Arg4154 residue is conserved across mammals and other organisms, and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) suggest that the variant Cys may impact the protein; however, this information is not predictive enough to assume pathogenicity. The variant occurs outside of the splicing consensus sequence and 1 of 5 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) predict a greater than 10% difference in splicing; this is not very predictive of pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.